+Search query
-Structure paper
Title | CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia. |
---|---|
Journal, issue, pages | Blood, Vol. 139, Page 2227-2239, Year 2022 |
Publish date | May 15, 2019 (structure data deposition date) |
Authors | Bennett, C. / Lawrence, M. / Guerrero, J.A. / Stritt, S. / Waller, A.K. / Yan, Y. / Mifsud, R.W. / Ballester-Beltran, J. / Baig, A. / Mueller, A. ...Bennett, C. / Lawrence, M. / Guerrero, J.A. / Stritt, S. / Waller, A.K. / Yan, Y. / Mifsud, R.W. / Ballester-Beltran, J. / Baig, A. / Mueller, A. / Mayer, L. / Warland, J. / Penkett, C.J. / Akbari, P. / Moreau, T. / Evans, A.L. / Mookerjee, S. / Hoffman, G.J. / Saeb-Parsy, K. / Adams, D.J. / Couzens, A.L. / Bender, M. / Erber, W.N. / Nieswandt, B. / Read, R.J. / Ghevaert, C. |
External links | Blood / PubMed:35051265 |
Methods | X-ray diffraction |
Resolution | 1.61 - 1.97 Å |
Structure data | PDB-6rpx: PDB-6rpy: PDB-6rpz: |
Chemicals | ChemComp-HOH: ChemComp-HG: |
Source |
|
Keywords | BLOOD CLOTTING / platelet development / fibronectin domain / SPRY domain |